⌘K
Loading ticker…
As of 2026-08-24, GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) has a 3-month relative strength percentile of 50 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 51. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 1.8%, relative volume 0.73×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.
GSK is held by 7 ETFs as of May 2026. Top owner: AVDE at 0.39% weight, $66M notional. Top 3 carry $99M.
Held by 36 ETFs · $339M across latest filings · largest weight 95.56% (GSKH).
Top 7 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| AVDE | 0.39% | $66M | −0.06 pp |
| AVIV | 1.12% | $20M | — |
| GMOI | 2.86% | $13M | −0.28 pp |
| APIE | 0.34% | $4M | −0.12 pp |
| AVSD | 0.53% | $2M | −0.10 pp |
| GINX | 1.07% | $1M | +0.13 pp |
| DIVY | 3.50% | $995K | −1.06 pp |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GSK Jan avg: 4.07% median: 4.75% win: 100% σ: 2.63% n: 4 2022-04-12 → 2026-07-31 | GSK Feb avg: 6.15% median: 6.41% win: 75% σ: 7.11% n: 4 2022-04-12 → 2026-07-31 | GSK Mar avg: 0.63% median: 2.69% win: 75% σ: 4.90% n: 4 2022-04-12 → 2026-07-31 | GSK Apr avg: -1.40% median: -2.58% win: 40% σ: 3.36% n: 5 2022-04-12 → 2026-07-31 | GSK May avg: -0.44% median: -3.05% win: 40% σ: 5.89% n: 5 2022-04-12 → 2026-07-31 | GSK Jun avg: -2.29% median: -0.84% win: 40% σ: 8.10% n: 5 2022-04-12 → 2026-07-31 | GSK Jul avg: -5.33% median: -1.39% win: 20% σ: 9.71% n: 5 2022-04-12 → 2026-07-31 | GSK Aug avg: -1.04% median: 2.77% win: 50% σ: 15.78% n: 4 2022-04-12 → 2026-07-31 (current) | GSK Sep avg: -1.08% median: -1.86% win: 50% σ: 8.54% n: 4 2022-04-12 → 2026-07-31 | GSK Oct avg: 2.42% median: 3.53% win: 50% σ: 10.25% n: 4 2022-04-12 → 2026-07-31 | GSK Nov avg: 0.02% median: 1.47% win: 75% σ: 4.99% n: 4 2022-04-12 → 2026-07-31 | GSK Dec avg: 1.53% median: 2.03% win: 75% σ: 1.72% n: 4 2022-04-12 → 2026-07-31 |